Udayavni Special
  • Home
  • Oxford-AstraZeneca

EU agrees potential 1.8 billion-dose purchase of Pfizer jab

Oxford-AstraZeneca jabs effective against severe COVID-19, new trial in US confirms

Nepal gives emergency use approval to Bharat Biotech’s Covaxin

Bharat Biotech’s Covaxin 81 pc efficient in Phase 3 trials

18-19 anti-COVID-19 vaccines in pipeline says Health Min Vardhan

South Africa suspends AstraZeneca vaccine drive

COVID-19 vaccines sent by India reach Bhutan and Maldives

UK approval of Oxford-AstraZeneca COVID-19 vaccine positive news, waiting for India’s approval: SII

Oxford-AstraZeneca’s COVID vaccine can be available in 1st half of next year: Official

Country’s first mRNA vaccine candidate by Gennova gets nod for conducting human trials: DBT

Serum Institute seeks emergency use authorisation for Covishield vaccine in India

Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

KEM Hospital starts trials of Oxford-AstraZeneca Covid-19 vaccine candidate in Mumbai

Latest Additions

Yuzvendra Chahal donates Rs 2 lakh for a COVID-19 patient in Bengaluru

UK, US scientists call for fuller probe into COVID-19 Wuhan lab leak theory

BSY’s ex-media advisor Mahadeva Prakash dies of Covid

Kolar: Covaxin manufacturing unit to be set up in Malur

Tauktae likely to intensify into ”very severe cyclonic” storm with wind speed up to 175 kmph: IMD

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.